Goldman Sachs Upgrades Smith & Nephew (SNN) to Neutral
More News related to SNN
- BMO Downgrades Smith & Nephew (SNN) to Market Perform
- Smith & Nephew Plc - Total Voting Rights
- Morgan Stanley Downgrades Smith & Nephew (SNN) to Underweight
- New Guide System Provides for Consistent, Accurate Portal Placement During Hip Surgery
- US District Court Enters Final Judgment in Favor of Smith & Nephew; Permanent Injunction Prohibits Arthrex Inc. From Selling Infringing Medical Devices
Goldman Sachs upgrades Smith & Nephew plc (NYSE: SNN) from Sell to Neutral.
Smith & Nephew plc, together with its subsidiaries, engages in the development, manufacture, and marketing of medical devices to medical and surgical service providers worldwide.
Related Categories
UpgradesStocks Mentioned
-2.61Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
